Patient programmer for implantable drug delivery device

• US 9,968,734 B2
• Filed: 10/03/2017
• Issued: 05/15/2018
• Est. Priority Date: 04/16/2015
• Status: Active Grant

• Current Assignee: FLO, LLC
• Original Assignee: Flowonix Medical, Inc.
• Inventors: Burke, Paul, Adler, Steve
• Primary Examiner(s): Garcia, Santiago
• Application Number:
  US15/723,378
• Publication Number:
  US 20180021510A1
• Time in Patent Office: 224 Days
• Field of Search: 34087007
• CPC Class Codes: A61B 5/0026 characterised by the transmission medium
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2205/04 implanted
• CPC Class Codes: A61M 2205/3523 using telemetric means
• CPC Class Codes: A61M 2205/3553 remote, e.g. between patient's home and doctor's office
• CPC Class Codes: A61M 2205/3592 using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 2205/52 with memories providing a history of measured variating parameters of apparatus or patient
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: G16H 20/17 delivered via infusion or injection

Abstract

Methods for programming an implantable drug delivery device using a mobile computing device that include establishing a connection with a telemetry unit configured for wireless communication with the implantable drug delivery device, displaying user-selectable drug delivery settings for the implantable drug delivery device, receiving at least one selection of a drug delivery setting, translating the received selection into a signal format readable by the telemetry unit, and sending the translated signal to the telemetry unit to program the implantable drug delivery device. Further embodiments include telemetry units for communication with an implantable drug delivery device, and patient programmers and a method for patient modification to a programmed drug delivery regimen.

Claims

1. A device for communicating with implantable drug delivery devices, comprising:

an input component;

a feedback component;

a first communication interface configured to communicate with an implantable drug delivery device that is configured to administer a preprogrammed drug delivery regimen;

a second communication interface, different from the first communication interface, configured to communicate with a mobile communication device;

a memory; and

a processor coupled to the input component, the feedback component, the first communication interface, the second communication interface, and the memory, and configured with processor-executable instructions to perform operations comprising;

receiving, via the input component, a request to modify the preprogrammed drug delivery regimen;

determining whether the requested modification to the preprogrammed drug delivery regimen is allowed in response to receiving the request to modify the preprogrammed drug delivery regimen via the input component;

transmitting the requested modification to the preprogrammed drug delivery regimen to the implantable drug delivery device via the first communication interface in response to determining that the requested modification is allowed; and

displaying an indication on the feedback component of whether the received request to modify the preprogrammed drug delivery regimen is allowed.

2. The device of claim 1, wherein:

the input component includes one or more of a key, a keypad, a switch, or a button; and

receiving, via the input component, the request to modify the preprogrammed drug delivery regimen comprises detecting a user press on the input component.

3. The device of claim 1, wherein the feedback component includes one or more of a liquid crystal display (LCD) screen, a light emitting diode (LED) indicator, a touchscreen display, or an audio feedback device.

4. The device of claim 1, wherein the processor is configured with processor-executable instructions to perform further operations comprising determining whether the modification to the preprogrammed drug delivery regimen was successfully implemented by the implantable drug delivery device based on signals received via the first communication interface, and

wherein the processor is configured with processor-executable instructions to perform operations such that displaying the indication on the feedback component of whether the received request to modify the preprogrammed drug delivery regimen is allowed comprises displaying an indication on the feedback component of whether the modification to the preprogrammed drug delivery regimen was successfully implemented by the implantable drug delivery device.

5. The device of claim 1, wherein the processor is configured with processor-executable instructions to perform operations further comprising:

receiving, via the second communication interface, the preprogrammed drug delivery regimen from the mobile communication device; and

transmitting, to the implantable drug delivery device via the first communication interface, the preprogrammed drug delivery regimen received from the mobile communication device.

6. The device of claim 1, wherein:

the processor is configured with processor-executable instructions to perform operations further comprising;

receiving, via the second communication interface, one or more parameters associated with allowable modifications to the preprogrammed drug delivery regime; and

storing the one or more parameters associated with the allowable modifications to the preprogrammed drug delivery regime in the memory;

the one or more parameters include one or more of;

a total number of doses permitted to be requested by a patient;

a number of doses permitted to be requested in a given time period;

a minimum wait time between successive requests for an additional dose;

a volume of each dose;

or a time of day in which a dose may be administered; and

the processor is configured with processor-executable instructions to perform operations such that determining whether the modification to the preprogrammed drug delivery regimen is allowed is based on the one or more parameters associated with the allowable modifications to the preprogrammed drug delivery regime stored in the memory.

7. The device of claim 1, wherein the first communication interface comprises a magnetic coil configured to communication using a magnetic-based pulse position modulation (PPM) protocol, and the second communication interface comprises a two-way wireless communication interface.

8. The device of claim 1, wherein the processor is configured with processor-executable instructions to perform operations further comprising:

receiving, via the first communication interface, information from the implantable drug delivery device;

storing in the memory information received from the implantable drug delivery device; and

transmitting the information received from the implantable drug delivery device to the mobile communication device via the second communication interface in a format configured to be enable the mobile communication device to generate a user interface display of the information.

9. The device of claim 1, wherein the second communication interface comprises a wired communication interface, a wireless communication interface, or both wired and wireless communication interfaces.

10. The device of claim 1, wherein the second communication interface comprises a Universal Serial Bus (USB) port.

11. The device of claim 1, wherein the second communication interface comprises a short range wireless communication interface.

12. The device of claim 1, wherein the processor is configured with processor-executable instructions to perform operations further comprising:

determining whether the mobile communication device is within a predetermined proximity threshold of the device;

establishing, via the second communication interface, a communication link with the mobile communication device in response to determining that the mobile communication device is within the predetermined proximity threshold.

13. The device of claim 1, wherein the device is configured to be physically coupled to the mobile computing device.

14. The device of claim 1, wherein the request to modify the preprogrammed drug delivery regimen comprises a request for an extra dose of a drug, and determining whether the requested modification to the preprogrammed drug delivery regimen is allowed comprises determining whether administering an extra dose of the drug is permissible within the preprogrammed drug delivery regimen.

15. A method of programming an implantable drug delivery device, comprising:

establishing, via a first communication interface of a device, a first communication link with a mobile communication device;

receiving, by the device, a preprogrammed drug delivery regimen from the mobile communication device over the first communication link;

establishing, via a second communication interface of the device, a second communication link with the implantable drug delivery device;

transmitting the preprogrammed drug delivery regimen from the device to the implantable drug delivery device over the second communication link;

receiving, via an input component of the device, a request to modify the preprogrammed drug delivery regimen;

determining, by the device, whether a modification to the preprogrammed drug delivery regimen is allowed in response to receiving the request to modify the preprogrammed drug delivery regimen via the input component of the device;

transmitting, via the first communication interface of the device, instructions to modify the preprogrammed drug delivery regimen to the implantable drug delivery device in response to determining that the modification to the preprogrammed drug delivery regimen is allowed; and

displaying, via a feedback component of the device, an indication of whether the request to modify the preprogrammed drug delivery regimen was successful.

16. The method of claim 15, wherein receiving the request to modify the preprogrammed drug delivery regimen comprises receive a request for an extra dose of a drug administered by the implantable drug delivery device, and

wherein determining whether the modification to the preprogrammed drug delivery regimen is allowed comprises determining, by the device, whether an extra dose of a drug provided by the implantable drug delivery device is permitted by the preprogrammed drug delivery regimen.

17. The method of claim 15, wherein displaying the indication of whether the request to modify the preprogrammed drug delivery regimen was successful comprises:

displaying, via the feedback component of the device, a first indication that the request to modify the preprogrammed drug delivery regimen failed in response to determining that the modification to the preprogrammed drug delivery regimen is not allowed; and

displaying, via the feedback component of the device, a second indication that the request to modify the preprogrammed drug delivery regimen was successful in response to determining that the modification to the preprogrammed drug delivery regimen is allowed.

18. The method of claim 15, further comprising determining by the device whether instructions to modify the preprogrammed drug delivery regimen where implemented by the implantable drug delivery device,

wherein displaying the indication of whether the request to modify the preprogrammed drug delivery regimen was successful comprises:

displaying, via the feedback component of the device, a first indication that the request to modify the preprogrammed drug delivery regimen failed in response to determining that the modification to the preprogrammed drug delivery regimen is not allowed or that the instructions to modify the preprogrammed drug delivery regimen where not implemented by the implantable drug delivery device; and

displaying, via the feedback component of the device, a second indication that the request to modify the preprogrammed drug delivery regimen was successful in response to determining that the modification to the preprogrammed drug delivery regimen is allowed and that the instructions to modify the preprogrammed drug delivery regimen where implemented by the implantable drug delivery device.